RxDoctor Payments Data

Hannah Carlsen, DO

Family Medicine · Cedar Falls, IANPI 1720426166

Payments from drug & device makers

$495in general payments, 2019–2025

Across 33 payments — averaging $15.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$122
  • Sunovion Pharmaceuticals Inc.$100
  • AstraZeneca$94
  • Pfizer$66
  • Novartis$43
  • Teva Pharmaceuticals USA, Inc.$23
  • plus $46 from 3 others

What the payments were for

  • Food & beverage$495100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$495 in reported general payments places this provider in the 70th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa

Medicare billing

Part B allowed, 2024
$123,657
Medicare patients
437
Services billed
1,624

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban233$147,237
OxycontinOxycodone Hcl38$72,900
JardianceEmpagliflozin109$68,583
OzempicSemaglutide57$50,871
JanuviaSitagliptin Phosphate28$25,829
MounjaroTirzepatide21$24,562
XareltoRivaroxaban21$23,412
ArexvyRsvpref3 Antigen/As01e/Pf64$19,795
TrulicityDulaglutide20$19,764
Bydureon BciseExenatide Microspheres13$10,333
MyrbetriqMirabegron17$9,432
FarxigaDapagliflozin Propanediol17$8,987
ShingrixVaricella-Zoster Ge/As01b/Pf40$8,886
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog15$7,965
LinzessLinaclotide13$6,173

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$66$147,237233 claims
Novo NordiskOzempic$16$50,87157 claims
Lilly USA, LLCMounjaro, Trulicity$12$44,32641 claims
Astellas Pharma US IncMyrbetriq$17$9,43217 claims
AstraZenecaFarxiga$94$8,98717 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,357 family medicine providers in Iowa.

Other family medicine in Cedar Falls

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →